Table 1.
Clinical characteristics of patients.
| Characteristic | Value |
|---|---|
| Age (years) | 67.03 ± 13.03 |
| Sex | |
| Male | 197 (46.20) |
| Female | 229 (53.80) |
| Type of stroke | |
| Ischemic | 278 (65.30) |
| Hemorrhagic | 148 (34.70) |
| Comorbidities | |
| Hypertension | 260 (61.00) |
| Arrhythmia | 74 (17.40) |
| Diabetes mellitus | 158 (37.10) |
| Dyslipidemia | 325 (76.30) |
| Coronary artery disease | 22 (5.20) |
| Heart failure | 70 (16.40) |
| Medication | |
| Beta blocker | 87 (20.40) |
| Calcium channel blocker | 193 (45.30) |
| ACE-i/ARB | 199 (46.70) |
| Diuretics | 228 (53.50) |
| MMSE | 14.08 ± 8.25 |
| MBI | 39.35 ± 17.62 |
| BMI (kg/m2) | 21.66 ± 2.06 |
| Nutritional biomarkers | |
| Albumin (g/dL) | 2.99 ± 0.58 |
| Prealbumin (mg/dL) | 19.36 ± 3.72 |
| Transferrin (mg/dL) | 246.77 ± 99.62 |
| HRV parameter (Frequency domain) | |
| VLF (ms2) | 619.06 ± 223.28 |
| LF (ms2) | 421.44 ± 154.90 |
| HF (ms2) | 179.04 ± 71.17 |
| LF/HF ratio | 5.55 ± 2.66 |
| HRV parameter (Time domain) | |
| SDNN (ms) | 100.51 ± 28.52 |
| SDANN (ms) | 101.87 ± 29.10 |
| ASDNN (ms) | 50.03 ± 11.74 |
| rMSSD (ms) | 26.34 ± 6.23 |
| pNN50 (%) | 49.41 ± 23.60 |
Values are presented as the mean ± standard deviation or number (%). ACE-I, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; MMSE, Mini-Mental State Examination; MBI, modified Barthel index; BMI, body mass index; HRV, heart rate variability; VLF, very low frequency; LF, low frequency; HF, high frequency; SDNN, standard deviation of intervals of all normal beats; SDANN, standard deviation of five-minute mean R-R interval; ASDNN, mean of five-minute standard deviations of intervals; rMSSD, root mean square of the difference of successive R-R intervals; pNN50, percentage of intervals that were more than 50 ms different from the previous interval.